微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.93% | -4.23% | 110.34% | 34/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.77% | -12.93% | 69.82% | 50/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.22% | -22.65% | -66.87% | 49/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 6.7% | 7.03% | -19.08% | 48/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 8.28% | 7.39% | 91.22% | 38/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.33% | 8.52% | 50.87% | 46/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.87% | 16.67% | -54.15% | 38/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 6.26% | -10.57% | -18.81% | 52/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.71% | -7.78% | 93.23% | 42/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.99% | -11.53% | 62.2% | 52/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.46% | 6.03% | -64.86% | 49/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 7% | 11.64% | -16.27% | 57/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.36% | -2.56% | 85.37% | 41/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.51% | 15.35% | 94.4% | 51/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.32% | 13.73% | -63% | 51/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 6.27% | -33.72% | -26.92% | 67/159 | 0.75% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 8.58% | -38.41% | 119.44% | 46/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.91% | -55.06% | 91.67% | 68/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.04% | 2% | -78.44% | 64/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.46% | -33.33% | -32.09% | 57/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.93% | 10.03% | 60.11% | 20/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.7% | -5.95% | -38.69% | 27/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 14.19% | -15.44% | -15.44% | 33/159 | 2.53% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 16.78% | 39.02% | 39.02% | 26/159 | 6.99% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-12-31 | 12.07% | -19.69% | -19.69% | 38/159 | 9.61% | 奥赛康 | 35% | 行业排名> |
| 2016-12-31 | 15.03% | -7.85% | 62.49% | 36/159 | 6.19% | 奥赛康 | 28.15% | 行业排名> |
| 2016-06-30 | 9.25% | 2% | -43.29% | 17/159 | 3.48% | 宏源药业 | 21.91% | 行业排名> |
| 2015-12-31 | 16.31% | 16% | 28.83% | 31/159 | 11.27% | 奥赛康 | 9.7% | 行业排名> |
| 2015-09-30 | 12.66% | 2% | -9.96% | 15/159 | 7.22% | 奥赛康 | 40.69% | 行业排名> |